Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,611 | 102 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $322.74 | 21 | $0 (2019) |
| PFIZER INC. | $152.52 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $137.72 | 4 | $0 (2018) |
| Amgen Inc. | $128.75 | 8 | $0 (2018) |
| Celgene Corporation | $122.80 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $115.70 | 9 | $0 (2019) |
| Genentech USA, Inc. | $95.53 | 7 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $63.34 | 5 | $0 (2018) |
| Lilly USA, LLC | $48.01 | 4 | $0 (2017) |
| Millennium Pharmaceuticals, Inc. | $47.49 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $61.93 | 4 | Merck Sharp & Dohme Corporation ($27.09) |
| 2018 | $295.85 | 16 | AstraZeneca Pharmaceuticals LP ($100.00) |
| 2017 | $1,253 | 82 | Novartis Pharmaceuticals Corporation ($254.80) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2019 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), SANDOSTATIN, VOTRIENT | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.09 | General |
| 06/06/2019 | PFIZER INC. | BAVENCIO (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2018 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: BioOncology | ||||||
| 07/31/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $78.49 | General |
| Category: Oncology | ||||||
| 05/10/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2018 | Genentech USA, Inc. | Avastin (Biological), Alecensa, TECENTRIQ | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: BioOncology | ||||||
| 02/28/2018 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Oncology | ||||||
| 02/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.31 | General |
| Category: Cardiovascular | ||||||
| 02/21/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), SANDOSTATIN LAR | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: ONCOLOGY | ||||||
| 02/19/2018 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Oncology | ||||||
| 02/12/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Oncology | ||||||
| 02/06/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2018 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: BioOncology | ||||||
| 01/31/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: BioOncology | ||||||
| 01/25/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), TYKERB | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2018 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Oncology | ||||||
| 01/11/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.34 | General |
| Category: Cardiovascular | ||||||
| 01/09/2018 | PFIZER INC. | SUTENT (Drug), XALKORI, INLYTA | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 12/21/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 12/18/2017 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Oncology | ||||||
| 12/14/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2017 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/06/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), KISQALI, VOTRIENT | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 291 | 459 | $337,692 | $48,997 |
| 2022 | 18 | 411 | 621 | $154,452 | $32,621 |
| 2021 | 7 | 209 | 314 | $87,511 | $26,914 |
| 2020 | 2 | 72 | 123 | $33,475 | $8,347 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 12 | 14 | $154,742 | $15,841 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 72 | $26,850 | $6,871 | 25.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 32 | 50 | $46,850 | $4,980 | 10.6% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 15 | 17 | $5,544 | $4,364 | 78.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 62 | $30,442 | $3,439 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $14,116 | $3,224 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 23 | $11,406 | $2,919 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $13,362 | $2,790 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 19 | $4,748 | $1,243 | 26.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 26 | $15,288 | $1,219 | 8.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 17 | $5,348 | $1,050 | 19.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 53 | $7,261 | $565.24 | 7.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 44 | 59 | $1,735 | $492.34 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 83 | $23,032 | $7,714 | 33.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 33 | 48 | $34,656 | $5,005 | 14.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $15,845 | $4,263 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 20 | $9,166 | $2,776 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 45 | $7,733 | $2,698 | 34.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 37 | 46 | $14,306 | $2,326 | 16.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 12 | $8,108 | $1,671 | 20.6% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 11 | 24 | $7,176 | $1,393 | 19.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 12 | $4,705 | $938.02 | 19.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 21 | 30 | $5,160 | $763.80 | 14.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 14 | $3,939 | $762.07 | 19.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 32 | 55 | $4,785 | $606.65 | 12.7% |
About Dr. Sindhu Singh, MD
Dr. Sindhu Singh, MD is a Internal Medicine healthcare provider based in Appleton, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1871710483.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sindhu Singh, MD has received a total of $1,611 in payments from pharmaceutical and medical device companies, with $61.93 received in 2019. These payments were reported across 102 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,611).
As a Medicare-enrolled provider, Singh has provided services to 983 Medicare beneficiaries, totaling 1,517 services with total Medicare billing of $116,879. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology, Medical Oncology
- Location Appleton, WI
- Active Since 04/18/2007
- Last Updated 07/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871710483
Products in Payments
- AFINITOR (Drug) $176.91
- Neulasta (Biological) $102.82
- Revlimid (Drug) $91.89
- LYNPARZA (Drug) $78.49
- ELIQUIS (Drug) $61.77
- IMFINZI (Drug) $59.23
- KEYTRUDA (Biological) $53.43
- GILOTRIF (Drug) $46.05
- ELITEK (Drug) $44.89
- PROVENGE (Drug) $43.78
- IBRANCE (Drug) $43.47
- JADENU (Drug) $42.28
- SUTENT (Drug) $38.49
- ERBITUX (Drug) $36.87
- DARZALEX (Biological) $35.12
- Imbruvica (Drug) $30.30
- Avastin (Biological) $30.08
- Lenvima (Drug) $29.81
- KISQALI (Drug) $26.53
- TASIGNA (Drug) $23.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Appleton
Dr. Kevin Chen, Md, MD
Internal Medicine — Payments: $15,887
Dr. Scott Parrish, M.d, M.D
Internal Medicine — Payments: $12,312
Dirk Steinert, Md, MD
Internal Medicine — Payments: $9,613
Karen Hansen, Md, MD
Internal Medicine — Payments: $8,062
Mr. Li Zhou, Md, MD
Internal Medicine — Payments: $6,227
Mr. Brian Guttormsen, Md, MD
Internal Medicine — Payments: $6,216